Weaver C. Barksdale & Associates’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,616
Closed -$1.21M 64
2022
Q3
$1.21M Sell
38,616
-1,774
-4% -$65.7K 1.22% 57
2022
Q2
$1.53M Buy
40,390
+2,458
+6% +$106K 1.43% 48
2022
Q1
$1.7M Buy
37,932
+511
+1% +$25.1K 1.51% 42
2021
Q4
$1.95M Buy
+37,421
New +$1.81M 1.77% 28
2016
Q3
Sell
-140
Closed -$12K 547
2016
Q2
$12K Hold
140
0.02% 200
2016
Q1
$12K Hold
140
0.01% 237
2015
Q4
$12K Hold
140
0.01% 226
2015
Q3
$12K Hold
140
0.01% 225
2015
Q2
$12K Hold
140
0.01% 243
2015
Q1
$12K Hold
140
0.01% 249
2014
Q4
$11K Hold
140
0.01% 250
2014
Q3
$8K Sell
140
-12,209
-99% -$801K 0.01% 299
2014
Q2
$915K Hold
12,349
0.74% 33
2014
Q1
$815K Sell
12,349
-1,710
-12% -$107K 0.68% 37
2013
Q4
$808K Sell
14,059
-226
-2% -$13.1K 0.68% 35
2013
Q3
$769K Hold
14,285
0.71% 35
2013
Q2
$631K Buy
+14,285
New +$696K 0.62% 40

Other funds holding WBA

Weaver C. Barksdale & Associates's WBA Position: Q4 2022 in Review

Weaver C. Barksdale & Associates sold out of Walgreens Boots Alliance (WBA) in Q4 2022, closing a stake of 38,616 shares — an estimated $1.21M sold.

Weaver C. Barksdale & Associates first reported a position in WBA in Q2 2013 and held it in 17 quarters. The position peaked at $1.95M in Q4 2021. 1,275 funds tracked by Wall St. Rank hold WBA as of Q4 2022.

  • Weaver C. Barksdale & Associates reported no remaining Walgreens Boots Alliance position as of Q4 2022 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 38,616 Walgreens Boots Alliance shares in Q4 2022, an estimated $1.21M.
  • Weaver C. Barksdale & Associates first reported a position in Walgreens Boots Alliance in Q2 2013 and held it in 17 quarters.
  • Weaver C. Barksdale & Associates's Walgreens Boots Alliance position peaked at $1.95M in Q4 2021.
  • 1,275 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2022.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.